Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% ointment versus triamcinolone acetonide 0.1% cream for chronic cheilitis
ChiCTR-IPR-17013527Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Stomatology, Sichuan University
- Start
- Jan 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus in chronic cheilitis (2 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoints: Dryness (physical sign), Desquamation (physical sign) and 3 more. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
chronic cheilitis
Beyond the preview
Go deeper on ChiCTR-IPR-17013527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013527.